404 related articles for article (PubMed ID: 11309329)
1. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.
Kelley MR; Cheng L; Foster R; Tritt R; Jiang J; Broshears J; Koch M
Clin Cancer Res; 2001 Apr; 7(4):824-30. PubMed ID: 11309329
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation.
Robertson KA; Bullock HA; Xu Y; Tritt R; Zimmerman E; Ulbright TM; Foster RS; Einhorn LH; Kelley MR
Cancer Res; 2001 Mar; 61(5):2220-5. PubMed ID: 11280790
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers.
Moore DH; Michael H; Tritt R; Parsons SH; Kelley MR
Clin Cancer Res; 2000 Feb; 6(2):602-9. PubMed ID: 10690545
[TBL] [Abstract][Full Text] [Related]
4. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
5. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
Fishel ML; Kelley MR
Mol Aspects Med; 2007; 28(3-4):375-95. PubMed ID: 17560642
[TBL] [Abstract][Full Text] [Related]
6. Redox regulation of the DNA repair function of the human AP endonuclease Ape1/ref-1.
Kelley MR; Parsons SH
Antioxid Redox Signal; 2001 Aug; 3(4):671-83. PubMed ID: 11554453
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of Ape1/ref-1 subcellular localization in non-small cell lung carcinomas.
Puglisi F; Aprile G; Minisini AM; Barbone F; Cataldi P; Tell G; Kelley MR; Damante G; Beltrami CA; Di Loreto C
Anticancer Res; 2001; 21(6A):4041-9. PubMed ID: 11911289
[TBL] [Abstract][Full Text] [Related]
8. Studies of apurinic/apyrimidinic endonuclease/ref-1 expression in epithelial ovarian cancer: correlations with tumor progression and platinum resistance.
Freitas S; Moore DH; Michael H; Kelley MR
Clin Cancer Res; 2003 Oct; 9(13):4689-94. PubMed ID: 14581338
[TBL] [Abstract][Full Text] [Related]
9. Going APE over ref-1.
Evans AR; Limp-Foster M; Kelley MR
Mutat Res; 2000 Oct; 461(2):83-108. PubMed ID: 11018583
[TBL] [Abstract][Full Text] [Related]
10. DNA repair-redox enzyme apurinic endonuclease in cervical cancer: evaluation of redox control of HIF-1alpha and prognostic significance.
Schindl M; Oberhuber G; Pichlbauer EG; Obermair A; Birner P; Kelley MR
Int J Oncol; 2001 Oct; 19(4):799-802. PubMed ID: 11562758
[TBL] [Abstract][Full Text] [Related]
11. The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer.
Xu Y; Moore DH; Broshears J; Liu L; Wilson TM; Kelley MR
Anticancer Res; 1997; 17(5B):3713-19. PubMed ID: 9427767
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone.
Luo M; Kelley MR
Anticancer Res; 2004; 24(4):2127-34. PubMed ID: 15330152
[TBL] [Abstract][Full Text] [Related]
13. Apurinic/apyrimidinic endonuclease expression in pediatric yolk sac tumors.
Thomson BG; Tritt R; Davis M; Perlman EJ; Kelley MR
Anticancer Res; 2000; 20(6B):4153-7. PubMed ID: 11205241
[TBL] [Abstract][Full Text] [Related]
14. Oxidative cellular damage and the reduction of APE/Ref-1 expression after experimental traumatic brain injury.
Lewén A; Sugawara T; Gasche Y; Fujimura M; Chan PH
Neurobiol Dis; 2001 Jun; 8(3):380-90. PubMed ID: 11447995
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of the DNA repair protein APE/REF-1 by CKII affects redox regulation of AP-1.
Fritz G; Kaina B
Oncogene; 1999 Jan; 18(4):1033-40. PubMed ID: 10023679
[TBL] [Abstract][Full Text] [Related]
16. Apurinic apyrimidinic endonuclease/redox effector factor 1 immunoreactivity and grading in hepatocellular carcinoma risk of relapse after liver transplantation.
Avellini C; Orsaria M; Baccarani U; Adani GL; Lorenzin D; Bresadola V; Bresadola F; Beltrami CA
Transplant Proc; 2010 May; 42(4):1204-8. PubMed ID: 20534262
[TBL] [Abstract][Full Text] [Related]
17. Nuclear expression of apurinic/apyrimidinic endonuclease increases with progression of ovarian carcinomas.
Tanner B; Grimme S; Schiffer I; Heimerdinger C; Schmidt M; Dutkowski P; Neubert S; Oesch F; Franzen A; Kölbl H; Fritz G; Kaina B; Hengstler JG
Gynecol Oncol; 2004 Feb; 92(2):568-77. PubMed ID: 14766249
[TBL] [Abstract][Full Text] [Related]
18. Alteration of APE1/ref-1 expression in non-small cell lung cancer: the implications of impaired extracellular superoxide dismutase and catalase antioxidant systems.
Yoo DG; Song YJ; Cho EJ; Lee SK; Park JB; Yu JH; Lim SP; Kim JM; Jeon BH
Lung Cancer; 2008 May; 60(2):277-84. PubMed ID: 18061304
[TBL] [Abstract][Full Text] [Related]
19. An exonucleolytic activity of human apurinic/apyrimidinic endonuclease on 3' mispaired DNA.
Chou KM; Cheng YC
Nature; 2002 Feb; 415(6872):655-9. PubMed ID: 11832948
[TBL] [Abstract][Full Text] [Related]
20. Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A.
Fan Z; Beresford PJ; Zhang D; Xu Z; Novina CD; Yoshida A; Pommier Y; Lieberman J
Nat Immunol; 2003 Feb; 4(2):145-53. PubMed ID: 12524539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
